TABLE 2.

Patients with Discordant PSMA/PSA-Based Responses

PatientPSAPSMA-TVNLDeathOS (mo)Late FU PETLate FU PSA
1−60%+61%4Yes10.5PDIncreased
243%+22%0No47CRDecreased
3158%+10%0No40CRDecreased
  • NL = new lesions; FU = follow-up; PD = progressive disease; CR = complete response.